149 related articles for article (PubMed ID: 24704995)
41. Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates.
Alaghehbandan R; Przybycin CG; Verkarre V; Mehra R
Asian J Urol; 2022 Jan; 9(1):1-11. PubMed ID: 35198391
[TBL] [Abstract][Full Text] [Related]
42. Expression of kidney-specific cadherin in chromophobe renal cell carcinoma and renal oncocytoma.
Adley BP; Gupta A; Lin F; Luan C; Teh BT; Yang XJ
Am J Clin Pathol; 2006 Jul; 126(1):79-85. PubMed ID: 16753598
[TBL] [Abstract][Full Text] [Related]
43. The use of immunohistochemical expression of SF-1 and EMA in distinguishing adrenocortical tumors from renal neoplasms.
Enriquez ML; Lal P; Ziober A; Wang L; Tomaszewski JE; Bing Z
Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):141-5. PubMed ID: 22553814
[TBL] [Abstract][Full Text] [Related]
44. Cannabinoid CB1 receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma.
Larrinaga G; Sanz B; Blanco L; Perez I; Candenas ML; Pinto FM; Irazusta A; Gil J; López JI
Clin Biochem; 2013 May; 46(7-8):638-41. PubMed ID: 23318578
[TBL] [Abstract][Full Text] [Related]
45. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
46. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
47. Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas.
Drendel V; Heckelmann B; Schell C; Kook L; Biniossek ML; Werner M; Jilg CA; Schilling O
Clin Proteomics; 2018; 15():25. PubMed ID: 30087584
[TBL] [Abstract][Full Text] [Related]
48. Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
Choi JH; Kim JW; Lee JY; Han WK; Rha KH; Choi YD; Hong SJ; Yoon YE
Korean J Urol; 2015 Oct; 56(10):695-702. PubMed ID: 26495070
[TBL] [Abstract][Full Text] [Related]
49. The MIB-1 tumor proliferation index in adult renal epithelial tumors with granular cytoplasm: biologic implications and differential diagnostic potential.
Tickoo SK; Amin MB; Linden MD; Zarbo RJ
Mod Pathol; 1998 Nov; 11(11):1115-21. PubMed ID: 9831210
[TBL] [Abstract][Full Text] [Related]
50. [Chromophobe renal cell carcinoma: a clinicopathologic study and immunophenotypes of 42 cases].
Zhang W; Yu WJ; Jiang YX; Li YJ; Han F; Liu Y; Han ZL
Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):76-80. PubMed ID: 22455881
[TBL] [Abstract][Full Text] [Related]
51. Discriminant nuclear features of renal oncocytoma and chromophobe renal cell carcinoma. Analysis of their potential utility in the differential diagnosis.
Tickoo SK; Amin MB
Am J Clin Pathol; 1998 Dec; 110(6):782-7. PubMed ID: 9844591
[TBL] [Abstract][Full Text] [Related]
52. Utility of cytokeratin 7 for distinguishing chromophobe renal cell carcinoma from renal oncocytoma.
Leroy X; Moukassa D; Copin MC; Saint F; Mazeman E; Gosselin B
Eur Urol; 2000 Apr; 37(4):484-7. PubMed ID: 10765081
[TBL] [Abstract][Full Text] [Related]
53. Hybrid chromophobe renal cell neoplasm.
Mai KT; Dhamanaskar P; Belanger E; Stinson WA
Pathol Res Pract; 2005; 201(5):385-9. PubMed ID: 16047948
[TBL] [Abstract][Full Text] [Related]
54. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
55. Can renal oncocytomas be distinguished from renal cell carcinoma on fine-needle aspiration specimens? A study of conventional smears in conjunction with ancillary studies.
Liu J; Fanning CV
Cancer; 2001 Dec; 93(6):390-7. PubMed ID: 11748579
[TBL] [Abstract][Full Text] [Related]
56. Expression of S-100 protein in renal cell neoplasms.
Lin F; Yang W; Betten M; Teh BT; Yang XJ;
Hum Pathol; 2006 Apr; 37(4):462-70. PubMed ID: 16564922
[TBL] [Abstract][Full Text] [Related]
57. Expression of vitamin D3 receptor in kidney tumors.
Liu W; Tretiakova M; Kong J; Turkyilmaz M; Li YC; Krausz T
Hum Pathol; 2006 Oct; 37(10):1268-78. PubMed ID: 16949927
[TBL] [Abstract][Full Text] [Related]
58. Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.
Cochand-Priollet B; Molinié V; Bougaran J; Bouvier R; Dauge-Geffroy MC; Deslignières S; Fournet JC; Gros P; Lesourd A; Saint-André JP; Toublanc M; Vieillefond A; Wassef M; Fontaine A; Groleau L
Arch Pathol Lab Med; 1997 Oct; 121(10):1081-6. PubMed ID: 9341588
[TBL] [Abstract][Full Text] [Related]
59. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
Zhu B; Rohan SM; Lin X
Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
[TBL] [Abstract][Full Text] [Related]
60. Immunohistochemical analysis of cytochrome C oxidase facilitates differentiation between oncocytoma and chromophobe renal cell carcinoma.
Adam AC; Scriba A; Ortmann M; Huss S; Kahl P; Steiner S; Störkel S; Büttner R
Appl Immunohistochem Mol Morphol; 2015 Jan; 23(1):54-9. PubMed ID: 25265428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
